共 110 条
- [1] Spencer K(2003)Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years’ prospective experience Br J Obstet Gynaecol 110 281-286
- [2] Spencer CE(1999)A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy associated plasma protein-A Ultrasound Obstet Gynecol 13 231-237
- [3] Power M(2002)One stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15,030 pregnancies Ultrasound Obstet Gynecol 20 219-225
- [4] Dawson C(1995)Effect of parity on human chorionic gonadotrophin levels and Down’s syndrome screening J Med Screen 2 28-30
- [5] Nicolaides KH(1988)Maternal serum screening for Down’s syndrome in early pregnancy BMJ 297 883-888
- [6] Spencer K(1998)The influence of smoking on maternal serum AFP and free beta hCG levels and the impact on screening for Down syndrome Prenat Diagn 18 225-234
- [7] Souter V(1984)Does smoking influence serum AFP levels in mid-trimester pregnancies? Br J Obstet Gynaecol 91 1189-1191
- [8] Tul N(1993)Adjustment formulae for maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking Prenat Diagn 13 123-130
- [9] Snijders R(2002)Maternal smoking, age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second trimester screening Prenat Diagn 22 247-255
- [10] Nicolaides KH(1990)The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydro-epiandrosterone sulphate levels Br J Obstet Gynaecol 97 272-274